4461

501 W ROOSEVELT RD
Chicago, IL 60607

Muhammad Bilal Azam

501 E 32nd St
Apt 614
Chicago, IL 60616

See QR code instructions at end of report

Your test results were NEGATIVE for COVID-19.

Your full lab report is included with this letter and should be used as proof of your test result
when such proof is requested.

We encourage you to contact your healthcare provider if you have any health concerns as a negative test
result may rarely occur in patients with a COVID-19 infection.

Please continue to take the necessary precautions including social distancing, hand hygiene, cough/sneeze
etiquette, using a face cover and proper surface cleaning to keep yourself and others around you healthy.

Sincerely,

Your Walgreens Pharmacy Team

To save your COVID-19 test results:

• Download and open a SMART Health Card-compatible app, such as CommonPass.
• Follow in-app instructions to save your COVID-19 test results.
Link to CommonPass download: https://thecommonsproject.org/shc

Customer Care: 1-800-WALGREENS www.walgreens.com Member of Walgreens Boots Alliance

 Aegis Sciences Corporation
501 Great Circle Road
Nashville, TN 37228
(615) 255-2400
Lab Director: Matthew T. Hardison, PhD
CLIA#: 44D2062333
Laboratory Report

Client Information
Client: WALGREENS CHICAGO 4461
Report To: Rushdi Alul
501 W ROOSEVELT RD
CHICAGO, IL 60607

Sample Information
Patient ID: 3006031525 PATIENT: Muhammad Azam
Lab Sample ID: 805858775 501 E 32nd St, Apt 614
Chicago IL, 60616
Specimen Type: Nasal - Anterior Nares
Cook
Collected: 12/04/2021 12:45 Central Time Phone: 312-647-6383
Received: 12/06/2021 DOB: 01/29/1994
Reported: 12/06/2021 Gender: Male
Ethnicity: Not Hispanic

Test(s) Requested
05700 SARS-CoV-2, RT-PCR
Tested For Result Reference Range
SARS-CoV-2, RT-PCR
SARS-CoV-2 NEGATIVE N/A
The Thermo Fisher Scientific, Inc. TaqPath COVID-19 Combo Kit used to perform this test has been authorized by FDA
under an Emergency Use Authorization for use by authorized laboratories. The test has not been otherwise FDA cleared or
approved. This test is authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or
pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization
of the emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under section 564(b)(1) of the
Act, 21 U.S.C. 360bbb-3(b)(1), unless the authorization is terminated or revoked.

Visit https://www.aegislabs.com/our-services/covid19-testing for COVID-19 testing resources

Page 1 of 1 12/6/2021 9:24:39 PM